The Experts below are selected from a list of 39 Experts worldwide ranked by ideXlab platform
Sheila Riazi - One of the best experts on this subject based on the ideXlab platform.
-
Malignant hyperthermia testing in probands without adverse Anesthetic Reaction.
Anesthesiology, 2015Co-Authors: Matthew A. Timmins, Carly Sterling, Henry Rosenberg, Natalia Kraeva, Marilyn Green Larach, Sheila RiaziAbstract:Background:Malignant hyperthermia (MH) is triggered by Reactions to Anesthetics. Reports link nonAnesthetic-induced MH-like Reactions to a variety of disorders. The objective of the authors was to retrospectively investigate the reasons for referrals for MH testing in nonAnesthetic cases and assess
-
Malignant hyperthermia testing in probands with NO adverse Anesthetic Reaction
BMC Anesthesiology, 2014Co-Authors: Carly Sterling, Henry Rosenberg, Natalia Kraeva, Sheila RiaziAbstract:Background Malignant hyperthermia (MH) is characterized by an adverse Reaction to volatile Anesthetic, and/or succinylcholine. Typically, following an adverse Anesthetic Reaction or positive family history, patients will undergo caffeine-halothane contracture (CHCT) and/ or genetic testing. However, sometimes patients with no individual or family history of Anesthetic Reaction are referred for MH testing due to a variety of reasons. The objective of our study was to investigate reasons for referrals in nonAnesthetic cases, and assess their phenotype.
-
Malignant hyperthermia in Canada: characteristics of index Anesthetics in 129 malignant hyperthermia susceptible probands.
Anesthesia and analgesia, 2014Co-Authors: Sheila Riazi, Marilyn Green Larach, Duminda N. Wijeysundera, Christine Massey, Natalia KraevaAbstract:BACKGROUND:Between 1992 and 2011, 373 Canadian individuals with adverse Anesthetic Reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario, Canada for malignant hyperthermia (MH) diagnostic testing. We analyzed the epidemiologic characteristics of the index adverse Anesthetics
Natalia Kraeva - One of the best experts on this subject based on the ideXlab platform.
-
Malignant hyperthermia testing in probands without adverse Anesthetic Reaction.
Anesthesiology, 2015Co-Authors: Matthew A. Timmins, Carly Sterling, Henry Rosenberg, Natalia Kraeva, Marilyn Green Larach, Sheila RiaziAbstract:Background:Malignant hyperthermia (MH) is triggered by Reactions to Anesthetics. Reports link nonAnesthetic-induced MH-like Reactions to a variety of disorders. The objective of the authors was to retrospectively investigate the reasons for referrals for MH testing in nonAnesthetic cases and assess
-
Malignant hyperthermia testing in probands with NO adverse Anesthetic Reaction
BMC Anesthesiology, 2014Co-Authors: Carly Sterling, Henry Rosenberg, Natalia Kraeva, Sheila RiaziAbstract:Background Malignant hyperthermia (MH) is characterized by an adverse Reaction to volatile Anesthetic, and/or succinylcholine. Typically, following an adverse Anesthetic Reaction or positive family history, patients will undergo caffeine-halothane contracture (CHCT) and/ or genetic testing. However, sometimes patients with no individual or family history of Anesthetic Reaction are referred for MH testing due to a variety of reasons. The objective of our study was to investigate reasons for referrals in nonAnesthetic cases, and assess their phenotype.
-
Malignant hyperthermia in Canada: characteristics of index Anesthetics in 129 malignant hyperthermia susceptible probands.
Anesthesia and analgesia, 2014Co-Authors: Sheila Riazi, Marilyn Green Larach, Duminda N. Wijeysundera, Christine Massey, Natalia KraevaAbstract:BACKGROUND:Between 1992 and 2011, 373 Canadian individuals with adverse Anesthetic Reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario, Canada for malignant hyperthermia (MH) diagnostic testing. We analyzed the epidemiologic characteristics of the index adverse Anesthetics
Marilyn Green Larach - One of the best experts on this subject based on the ideXlab platform.
-
Malignant hyperthermia testing in probands without adverse Anesthetic Reaction.
Anesthesiology, 2015Co-Authors: Matthew A. Timmins, Carly Sterling, Henry Rosenberg, Natalia Kraeva, Marilyn Green Larach, Sheila RiaziAbstract:Background:Malignant hyperthermia (MH) is triggered by Reactions to Anesthetics. Reports link nonAnesthetic-induced MH-like Reactions to a variety of disorders. The objective of the authors was to retrospectively investigate the reasons for referrals for MH testing in nonAnesthetic cases and assess
-
Malignant hyperthermia in Canada: characteristics of index Anesthetics in 129 malignant hyperthermia susceptible probands.
Anesthesia and analgesia, 2014Co-Authors: Sheila Riazi, Marilyn Green Larach, Duminda N. Wijeysundera, Christine Massey, Natalia KraevaAbstract:BACKGROUND:Between 1992 and 2011, 373 Canadian individuals with adverse Anesthetic Reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario, Canada for malignant hyperthermia (MH) diagnostic testing. We analyzed the epidemiologic characteristics of the index adverse Anesthetics
Gabriel Gastaminza - One of the best experts on this subject based on the ideXlab platform.
-
Early skin testing is effective for diagnosis of hypersensitivity Reactions occurring during anesthesia.
Allergy, 2013Co-Authors: Alberto Lafuente, Gracia Javaloyes, Felicia Berroa, Maria Jose Goikoetxea, Rafael Moncada, Jorge M. Núñez-córdoba, Paula Cabrera-freitag, Carmen M. D'amelio, Maria L. Sanz, Gabriel GastaminzaAbstract:Allergic skin tests have to be performed 4–6 weeks after an allergic Anesthetic Reaction. Patients with allergic Reactions during anesthesia were prospectively included (n = 44). Skin tests were performed in two stages: (i) Stage 1 (S1), 0–4 days after the Reaction; and (ii) Stage 2 (S2), 4–8 weeks after. Five (11.5%) surgical procedures were suspended due to the Reaction. Positive skin tests were obtained in 25/44 patients (57%). Allergic diagnosis was carried out at S1 in 15/25 (60%) and at S2 in 10/25 (40%). Three patients resulted positive only in S1. Overall agreement among S1 and S2 skin tests was 70.45%. The kappa statistic was 0.41 (P-value = 0.002). Odds ratio of obtaining a false negative in S1 (compared with S2) was 3.33. Early allergological study is useful, could minimize false negatives, but should be considered as a complement to late skin tests.
Carly Sterling - One of the best experts on this subject based on the ideXlab platform.
-
Malignant hyperthermia testing in probands without adverse Anesthetic Reaction.
Anesthesiology, 2015Co-Authors: Matthew A. Timmins, Carly Sterling, Henry Rosenberg, Natalia Kraeva, Marilyn Green Larach, Sheila RiaziAbstract:Background:Malignant hyperthermia (MH) is triggered by Reactions to Anesthetics. Reports link nonAnesthetic-induced MH-like Reactions to a variety of disorders. The objective of the authors was to retrospectively investigate the reasons for referrals for MH testing in nonAnesthetic cases and assess
-
Malignant hyperthermia testing in probands with NO adverse Anesthetic Reaction
BMC Anesthesiology, 2014Co-Authors: Carly Sterling, Henry Rosenberg, Natalia Kraeva, Sheila RiaziAbstract:Background Malignant hyperthermia (MH) is characterized by an adverse Reaction to volatile Anesthetic, and/or succinylcholine. Typically, following an adverse Anesthetic Reaction or positive family history, patients will undergo caffeine-halothane contracture (CHCT) and/ or genetic testing. However, sometimes patients with no individual or family history of Anesthetic Reaction are referred for MH testing due to a variety of reasons. The objective of our study was to investigate reasons for referrals in nonAnesthetic cases, and assess their phenotype.